XI'AN, CHINA -- (MARKET WIRE) -- December 14, 2006 -- Skystar Bio-Pharmaceutical (OTCBB: SKBI), a leading bio-pharmaceutical company in China, today announced that it will be added to the Ludlow China Small-Cap Index, a diversified stock index of Chinese stocks traded in the U.S. financial markets owned and operated by the New York-based investment banking firm Ludlow Capital, Inc.